Back to search results

RISE-CM for Opioid Use Disorder After Incarceration

This study is for adults (18+) currently in Clatsop County Jail who are taking medication for opioid use disorder (MOUD) and plan to continue it after release. Many people face a high risk of overdose after leaving jail, and staying on MOUD can help. This study is testing a program called Reentry Incentives and Support for Engagement with Contingency Management (RISE-CM). This program offers gift card rewards for attending MOUD and counseling appointments after you leave jail. The study aims to see how many participants receive MOUD at 1, 2, and 3 months after release. Around 75 people are expected to join.

Study design
This is an interventional study with a planned enrollment of 75 participants. It is testing the RISE-CM intervention.
What's involved
While incarcerated, you will complete one visit and may receive a small incentive for enrolling. After release, you can earn gift cards by attending your MOUD and counseling appointments.
Compensation
Participants may receive small incentives like commissary credit or snacks for enrolling, and gift cards for attending appointments after release.
Follow-up
The study will measure how many patients receive medication for opioid use disorder at 1, 2, and 3 months after release.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07322588

Reentry Incentives and Support for Engagement With Contingency Management

Not Yet Recruiting
NAAges 18+InterventionalTreatment
Oregon Health and Science University
~75 participants
Updated 2026-01-07 on ClinicalTrials.gov
What's tested:Reentry Incentives and Support for Engagement with Contingency Management (RISE-CM) Intervention

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of patients receiving medication for opioid use disorder
Measured over 1, 2, and 3 months

Conditions

Opioid Use Disorder

Explore related trials

Opioid Use Disorder

Where it's being run

1 sites across 1 states
Oregon1

Study leadership

  • Linda Peng, MD · PRINCIPAL_INVESTIGATOR · Oregon Health and Science University

Who to contact

Carol DeFrancesco Senior Research Associate
[email protected]
5033105036
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Be adults (age ≥18 years) currently incarcerated at Clatsop County Jail
Be enrolled in the jail's MOUD program at the time of recruitment
Plan to continue MOUD with Clatsop Behavioral Healthcare upon release
Speak English and be able to provide informed consent

Exclusion

Are unable to provide informed consent due to cognitive impairment or acute psychiatric instability
Are scheduled for transfer to a different facility or geographic location that prevents post-release participation

What this trial measures

  • Number of patients receiving medication for opioid use disorder1, 2, and 3 months

    We will assess patient reported receipt of medication for opioid use disorder and also use chart review to determine whether patients are receiving medications and three different time points.